British Columbia Investment Management Corp Aurinia Pharmaceuticals Inc. Transaction History

British Columbia Investment Management Corp

$15.9 Billion
Q4 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $1.99 Million - $4.29 Million	-182,067 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$10.0 - $14.52 $599,590 - $870,604	59,959 Added 49.1%	182,067 $2.36 Million
Q1 2021 Apr 30, 2021	SELL	$12.3 - $18.73 $613,130 - $933,653	-49,848 Reduced 28.99%	122,108 $1.59 Million
Q4 2020 Feb 02, 2021	SELL	$12.94 - $16.05 $307,881 - $381,877	-23,793 Reduced 12.15%	171,956 $2.37 Million
Q3 2020 Nov 10, 2020	BUY	$13.19 - $16.66 $381,151 - $481,424	28,897 Added 17.32%	195,749 $2.88 Million
Q2 2020 Aug 12, 2020	BUY	$14.12 - $18.33 $2.36 Million - $3.06 Million	166,852 New	166,852 $2.71 Million

Others Institutions Holding AUPH

# of Institutions

227

Shares Held

58.9M

Call Options Held

949K

Put Options Held

1.51M

Black Rock Inc. New York, NY

9.27M
Shares

$74.6 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

8.43M
Shares

$67.9 Million
5.69% of portfolio
Armistice Capital, LLC New York, NY

6.4M
Shares

$51.5 Million
0.81% of portfolio
Nea Management Company, LLC Timonium, MD

3.97M
Shares

$32 Million
2.55% of portfolio
State Street Corp Boston, MA

2.92M
Shares

$23.5 Million
0.0% of portfolio

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account